Valuation: Amoéba

Market Cap 5.23Cr 5.98Cr 4.8Cr 4.48Cr 8.49Cr 569.64Cr 8.63Cr 58Cr 22Cr 279.4Cr 22Cr 22Cr 962.74Cr P/E 2026 *
-10.1x
P/E 2027 * 75.9x
Enterprise Value 6.34Cr 7.26Cr 5.83Cr 5.43Cr 10Cr 691.12Cr 10Cr 70Cr 27Cr 338.99Cr 27Cr 27Cr 1.17TCr EV / Sales 2026 *
12.4x
EV / Sales 2027 * 4.12x
Free-Float
87.09%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 60 14/12/2023
Chief Tech/Sci/R&D Officer - 01/09/2018
Corporate Officer/Principal - 01/03/2022
Director TitleAgeSince
Director/Board Member 57 01/05/2024
Director/Board Member - 01/06/2014
Chairman 70 14/12/2023
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-11.21% - - 5.95Cr
-6.11%-17.29%+74.60%+30.83% 302.52Cr
+0.73%-8.83%-12.73%-23.56% 301.62Cr
-.--%-.--% - - 248.89Cr
+4.17%-2.87%-22.19%-31.87% 182.54Cr
+10.02%-0.86%+22.17%+7.13% 148.09Cr
+2.11%-1.71%-29.94% - 141.34Cr
+1.33%-6.70%-8.00%-48.87% 130.76Cr
+0.46%-9.36%-0.51%-17.22% 124.04Cr
+1.05%-4.21%-16.10%+15.18% 124.7Cr
Average +1.38%-0.98%+0.91%-9.77% 189.39Cr
Weighted average by Cap. +0.75%-2.60%+7.29%-6.98%

Financials

2026 *2027 *
Net sales 51L 58.37L 46.83L 43.67L 82.8L 56Cr 84.19L 5.64Cr 2.19Cr 27Cr 2.19Cr 2.14Cr 94Cr 1.56Cr 1.78Cr 1.43Cr 1.33Cr 2.52Cr 169.42Cr 2.57Cr 17Cr 6.66Cr 83Cr 6.68Cr 6.54Cr 286.33Cr
Net income -52L -59.51L -47.75L -44.53L -84.42L -57Cr -85.84L -5.75Cr -2.23Cr -28Cr -2.23Cr -2.19Cr -96Cr 6L 6L 5L 5L 9L 5.99Cr 9L 60.81L 23.57L 2.94Cr 23.63L 23.12L 10Cr
Net Debt 1.12Cr 1.28Cr 1.02Cr 95.48L 1.81Cr 121.48Cr 1.84Cr 12Cr 4.78Cr 60Cr 4.79Cr 4.69Cr 205.31Cr 1.18Cr 1.36Cr 1.09Cr 1.01Cr 1.92Cr 129.11Cr 1.96Cr 13Cr 5.08Cr 63Cr 5.09Cr 4.98Cr 218.2Cr
Logo Amoéba
Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.
Employees
-